USPharmacist | Weekly News Update


April 8, 2015
  • Pediatrics Group Calls for Metric-Only Dosing of
    Liquid Medications

    A teaspoon of sugar might help the medicine go down, but it shouldn’t be used to measure liquid drugs, according to a new policy statement from the American Academy of Pediatrics. Find out how pharmacists can help educate parents and caregivers in the correct way to dose children with liquid medications.

  • Routine Post-Fracture Bisphosphonates: Cost-Prohibitive for Older Women

    Hip fractures can be devastating injuries for older patients, and routine bisphosphonate treatment potentially could prevent about a fourth of them. Yet, here’s why a cost-benefit analysis recommends against routine bisphosphonate treatment of women over age 65, even after they suffer a distal radius fracture.

  • Statins: When Do Patients Without Existing Heart Disease Need Them

    Statins are routinely prescribed to patients with a history of heart disease and stroke. It’s the other group—those with high cholesterol but no cardiovascular disease—who often ask pharmacists whether they should be on statins. A new article provides some tips on answering those questions.

  • The Name Game: Controversy Continues on
    Biosimilar Naming Policy

    Biosimilars are just that—similar but not identical to existing drugs. As a result, a heated debate has emerged on the naming policy for them and whether they should share a name with an existing similar product. Find out how major pharmacy groups come down on the question.

U.S. Pharmacist Social Connect